
Trastuzumab Biosimilars Global Market Report 2025
Description
Trastuzumab Biosimilars Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on trastuzumab biosimilars market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for trastuzumab biosimilars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The trastuzumab biosimilars market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product: Ogivri; Herzuma; Ontruzant; Trazimera; Other Products
2) By Indication: Adjuvant Breast Cancer; Metastatic Breast Cancer; Metastatic Gastric Cancer; Other Indications
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy
Companies Mentioned: Pfizer Inc.; Merck & Co.; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Mylan NV
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on trastuzumab biosimilars market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for trastuzumab biosimilars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The trastuzumab biosimilars market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product: Ogivri; Herzuma; Ontruzant; Trazimera; Other Products
2) By Indication: Adjuvant Breast Cancer; Metastatic Breast Cancer; Metastatic Gastric Cancer; Other Indications
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy
Companies Mentioned: Pfizer Inc.; Merck & Co.; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Mylan NV
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Trastuzumab Biosimilars Market Characteristics
- 3. Trastuzumab Biosimilars Market Trends And Strategies
- 4. Trastuzumab Biosimilars Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Trastuzumab Biosimilars Growth Analysis And Strategic Analysis Framework
- 5.1. Global Trastuzumab Biosimilars PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Trastuzumab Biosimilars Market Growth Rate Analysis
- 5.4. Global Trastuzumab Biosimilars Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Trastuzumab Biosimilars Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Trastuzumab Biosimilars Total Addressable Market (TAM)
- 6. Trastuzumab Biosimilars Market Segmentation
- 6.1. Global Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ogivri
- Herzuma
- Ontruzant
- Trazimera
- Other Products
- 6.2. Global Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Adjuvant Breast Cancer
- Metastatic Breast Cancer
- Metastatic Gastric Cancer
- Other Indications
- 6.3. Global Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Online Pharmacy
- 7. Trastuzumab Biosimilars Market Regional And Country Analysis
- 7.1. Global Trastuzumab Biosimilars Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Trastuzumab Biosimilars Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Trastuzumab Biosimilars Market
- 8.1. Asia-Pacific Trastuzumab Biosimilars Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Trastuzumab Biosimilars Market
- 9.1. China Trastuzumab Biosimilars Market Overview
- 9.2. China Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Trastuzumab Biosimilars Market
- 10.1. India Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Trastuzumab Biosimilars Market
- 11.1. Japan Trastuzumab Biosimilars Market Overview
- 11.2. Japan Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Trastuzumab Biosimilars Market
- 12.1. Australia Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Trastuzumab Biosimilars Market
- 13.1. Indonesia Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Trastuzumab Biosimilars Market
- 14.1. South Korea Trastuzumab Biosimilars Market Overview
- 14.2. South Korea Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Trastuzumab Biosimilars Market
- 15.1. Western Europe Trastuzumab Biosimilars Market Overview
- 15.2. Western Europe Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Trastuzumab Biosimilars Market
- 16.1. UK Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Trastuzumab Biosimilars Market
- 17.1. Germany Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Trastuzumab Biosimilars Market
- 18.1. France Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Trastuzumab Biosimilars Market
- 19.1. Italy Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Trastuzumab Biosimilars Market
- 20.1. Spain Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Trastuzumab Biosimilars Market
- 21.1. Eastern Europe Trastuzumab Biosimilars Market Overview
- 21.2. Eastern Europe Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Trastuzumab Biosimilars Market
- 22.1. Russia Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Trastuzumab Biosimilars Market
- 23.1. North America Trastuzumab Biosimilars Market Overview
- 23.2. North America Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Trastuzumab Biosimilars Market
- 24.1. USA Trastuzumab Biosimilars Market Overview
- 24.2. USA Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Trastuzumab Biosimilars Market
- 25.1. Canada Trastuzumab Biosimilars Market Overview
- 25.2. Canada Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Trastuzumab Biosimilars Market
- 26.1. South America Trastuzumab Biosimilars Market Overview
- 26.2. South America Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Trastuzumab Biosimilars Market
- 27.1. Brazil Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Trastuzumab Biosimilars Market
- 28.1. Middle East Trastuzumab Biosimilars Market Overview
- 28.2. Middle East Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Trastuzumab Biosimilars Market
- 29.1. Africa Trastuzumab Biosimilars Market Overview
- 29.2. Africa Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Trastuzumab Biosimilars Market Competitive Landscape And Company Profiles
- 30.1. Trastuzumab Biosimilars Market Competitive Landscape
- 30.2. Trastuzumab Biosimilars Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Mylan NV Overview, Products and Services, Strategy and Financial Analysis
- 31. Trastuzumab Biosimilars Market Other Major And Innovative Companies
- 31.1. Fujifilm Kyowa Kirin Biologics Co. Ltd.
- 31.2. Innovent Biologics Inc.
- 31.3. STADA Arzneimittel AG
- 31.4. Apotex Inc.
- 31.5. Samsung Bioepis Co. Ltd.
- 31.6. Celltrion Inc.
- 31.7. Zydus Lifesciences Limited
- 31.8. BIOCAD
- 31.9. Shanghai Henlius Biotech Inc.
- 31.10. Biocon Limited
- 31.11. Alvotech Holdings S.A.
- 31.12. Polpharma Biologics S.A
- 31.13. EirGenix Inc.
- 31.14. Hetero Biopharma Limited
- 31.15. Mabion SA
- 32. Global Trastuzumab Biosimilars Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Trastuzumab Biosimilars Market
- 34. Recent Developments In The Trastuzumab Biosimilars Market
- 35. Trastuzumab Biosimilars Market High Potential Countries, Segments and Strategies
- 35.1 Trastuzumab Biosimilars Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Trastuzumab Biosimilars Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Trastuzumab Biosimilars Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.